explore -WSS

explore

author：fashion 2025-10-02 22:12:45 - browse：536

This is the online edition of Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered every Thursday to their inbox.

I have one more, admittedly braggy thing to say about last week’s STAT Breakthrough Summit West in San Francisco. Of course we curated an incredible roster of influential industry leaders to speak on stage. That’s what STAT does. But just as remarkable were the health care and health tech A-Listers who just showed up as summit attendees to listen and learn from their peers — like 23AndMe’s Anne Wojcicki. Please join us in San Francisco next year, or better yet, register for our next summit in Boston, Oct. 16-17.

I’m back in Boston from San Francisco, but flying out again next week, this time to Chicago for the annual meeting of the American Society of Clinical Oncology. How can we be knocking on June, already?

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： Element Biosciences CEO lays out genome sequencing strategy

focus

WSS

Dogs on Prozac: What pet anti

IRA could hurt research into orphan drugs for rare diseases

Private equity could exacerbate cardiology's overuse problem, experts fear

Listen: Covid's latest surge, Alnylam at the FDA, & the end of an era

IRA could hurt research into orphan drugs for rare diseases

Will the IRA bring competition to the biologics market?

knowledge

explore

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

explore

Wildfire smoke exposes gaps in outdoor worker protections

Bird flu in milk supply is likely coming from asymptomatic cows

After affirmative action ruling, medical educators look to 'holistic review'

A common UTI test for kids haunts adults as a traumatic 'nightmare'

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

What to make of Biden’s latest efforts on cancer research

Bright Health sells Medicare Advantage business to Molina

After traumatic brain injury, life support decisions can use more time

ChatGPT in medicine: STAT answers readers' burning questions

Getting Alzheimer's drug Leqembi to patients can be a challenge

hotspot

UnitedHealth financials solid despite Change Healthcare cyberattack

H5N1 bird flu virus started spreading in cows in Texas in December

Medical bills so high, Medicare adding extra digits to claim forms

New weight loss drugs vying to be the next Wegovy or Mounjaro

Walmart eyes Medicare Advantage provider ChenMed

How to make the FDA’s new prescription one

focus

Wikipedia

focus

hotspot